Treatment of Neuromyelitis Optica: Review and Recommendations.

Treatment of Neuromyelitis Optica: Review and Recommendations.

Toon andere (1) versies

Neuromyelitis optica (NMO) is an autoimmune demyelinating disease preferentially targeting the optic nerves and spinal cord. Once regarded as a variant of multiple sclerosis (MS), NMO is now recognized to be a different disease with unique pathology and immunopathogenesis that does not respond to tr...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Kimbrough, D, Fujihara, K, Jacob, A, Lana-Peixoto, M, Leite, M, Levy, M, Marignier, R, Nakashima, I, Palace, J, de Seze, J, Stuve, O, Tenembaum, SN, Traboulsee, A, Waubant, E, Weinshenker, BG, Wingerchuk, D
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2012

Gelijkaardige items

Treatment of neuromyelitis optica: Review and recommendations
door: Kimbrough, D, et al.
Gepubliceerd in: (2012)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
door: Pittock, S, et al.
Gepubliceerd in: (2019)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
door: Collongues, N, et al.
Gepubliceerd in: (2013)

Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
door: Mealy, M, et al.
Gepubliceerd in: (2014)

Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
door: Fujihara, K, et al.
Gepubliceerd in: (2014)

Treatment of neuromyelitis optica: an evidence based review
door: Douglas Sato, et al.
Gepubliceerd in: (2012-01-01)

Use of mitoxantrone in neuromyelitis optica.
door: Kitley, J, et al.
Gepubliceerd in: (2011)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
door: Kim, W, et al.
Gepubliceerd in: (2012)

The borderland of neuromyelitis optica.
door: Matthews, L, et al.
Gepubliceerd in: (2009)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
door: Elsone, L, et al.
Gepubliceerd in: (2012)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
door: Waters, P, et al.
Gepubliceerd in: (2015)

A practical guide to the treatment of neuromyelitis optica.
door: Palace, J, et al.
Gepubliceerd in: (2012)

Neuromyelitis optica associated with systemic autoimmune diseases in children
door: Russo RA, et al.
Gepubliceerd in: (2008-09-01)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
door: Nour, M, et al.
Gepubliceerd in: (2014)

Current and future treatment approaches for neuromyelitis optica
door: Nicolas Collongues, et al.
Gepubliceerd in: (2011-03-01)

Differential diagnosis of neuromyelitis optica spectrum disorders
door: Sung-Min Kim, et al.
Gepubliceerd in: (2017-07-01)

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
door: Cree, BAC, et al.
Gepubliceerd in: (2019)

Prevalence and clinical characteristics of neuromyelitis optica spectrum disorders patients with myelin oligodendrocyte glycoprotein antibodies
door: Sato, D, et al.
Gepubliceerd in: (2013)

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica
door: Nicolas Collongues, et al.
Gepubliceerd in: (2016-05-01)

Magnetic resonance imaging in neuromyelitis optica.
door: Tackley, G, et al.
Gepubliceerd in: (2014)

Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes
door: Marco A. Lana-Peixoto, et al.
Gepubliceerd in: (2019-06-01)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
door: Sato, D, et al.
Gepubliceerd in: (2014)

Racial differences in neuromyelitis optica spectrum disorder
door: Kim, S, et al.
Gepubliceerd in: (2018)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
door: Viegas, S, et al.
Gepubliceerd in: (2009)

The evolving clinical spectrum of neuromyelitis optica
door: Viegas, S, et al.
Gepubliceerd in: (2008)

Seasonal pattern of variation in neuromyelitis optica relapses
door: Elsone, L, et al.
Gepubliceerd in: (2012)

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
door: Luppe, S, et al.
Gepubliceerd in: (2012)

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder
door: Achim Berthele, et al.
Gepubliceerd in: (2023-04-01)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
door: Downer, J, et al.
Gepubliceerd in: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
door: Downer, J, et al.
Gepubliceerd in: (2012)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
door: Nour, M, et al.
Gepubliceerd in: (2015)

Good response to Ofatumumab in a child with severe relapsing Neuromyelitis Optica
door: Sedani, S, et al.
Gepubliceerd in: (2012)

A mathematical model of cellular swelling in Neuromyelitis optica
door: Laranjeira, S, et al.
Gepubliceerd in: (2017)

Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.
door: Leite, M, et al.
Gepubliceerd in: (2012)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
door: Matthews, L, et al.
Gepubliceerd in: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
door: Matthews, L, et al.
Gepubliceerd in: (2013)

Neuromyelitis Optica
door: Goyal V, et al.
Gepubliceerd in: (2009-10-01)

Neuromyelitis optica
door: Jacob Anu, et al.
Gepubliceerd in: (2007-01-01)

NMO-IgG in the diagnosis of neuromyelitis optica.
door: Jarius, S, et al.
Gepubliceerd in: (2007)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
door: Waters, P, et al.
Gepubliceerd in: (2016)